A new study found proprotein convertase subtilisin/kexin type 9 (PCSK9) is associated with an increased cutaneous melanoma risk.
2024
How Derm Deserts Are Harming Our Skin
Two years ago, in the fall of 2022, the American Dermatological Association (ADA) effectively declared war on health disparities in skincare, citing a concept many of us had not heard: medical deserts.
TIL Therapy: A New Melanoma Treatment 30 Years in the Making
Almost two-thirds of patients diagnosed with metastatic melanoma are expected to die within five years, but a newly approved treatment may help some patients live longer.
Age-related skin changes may contribute to melanoma metastases among older adults
Age-related changes to the skin’s elasticity may drive higher rates of metastatic skin cancer among older individuals, according to study results.